Galapagos NV American Depositary Shares is a leading biotechnology company that focuses on the discovery, development, and commercialization of innovative medicines. They have an extensive pipeline of potential therapies targeting various diseases, including inflammation, fibrosis, and cancer. With a strong commitment to scientific excellence, Galapagos NV is poised to make a significant impact in the healthcare industry.
